David E. Dill

David E. Dill, PharmD, MBA, currently serves as a Medical Science Liaison in Neuroscience at Catalyst Pharmaceuticals, Inc., focusing on epilepsy, neuromuscular conditions, and rare diseases since May 2023. Prior experience includes a Post-Doctoral Fellowship in Medical Affairs and Strategy at Biohaven, where involvement included products such as Nurtec® ODT and BHV-7000. David also held roles as a Clinical Instructor in Pharmacy Practice at Saint Joseph's University and as a Pharmacy Intern at Delaware Psychiatric Center, gaining experience in complex psychiatric care and formulary management. David's extensive training includes multiple Pharmacy Externships with institutions like the U.S. Department of Veterans Affairs and Spark Therapeutics, emphasizing advanced pharmacy practice. Academic qualifications comprise an MBA from Saint Joseph's University and a PharmD from the University of the Sciences in Philadelphia.